EP14.01-015 IMforte: A Phase III Study of Lurbinectedin and Atezolizumab Versus Atezolizumab as Maintenance Therapy in ES-SCLC

L. Paz-Ares, M. Reck, S. Peters, H. Borghaei, R. Herbst, M. Siddiqui, V. Cuchelkar, K. Bhatt, D. Chakrabarti, L. Wang, S. Morris, S.V. Liu